Deucravacitinib Shows Durable Efficacy in Psoriasis Over 2 Years, finds study Dr. Shravani Dali11 Jan 2026 9:00 PM ISTResearchers have found in a new study that in a real-world Japanese cohort, deucravacitinib 6 mg provided sustained disease control in patients with...
Hydrocolloid Dressings Match Petroleum Ointment After Skin Surgery: JAMA Dr Riya Dave9 Jan 2026 8:00 PM ISTA recent study has shown that hydrocolloid dressings do not confer a clear advantage or disadvantage in terms of scar appearance or overall...
Blood Metabolites May Have Causal Links with Alopecia Areata: Study Dr. Shravani Dali8 Jan 2026 8:45 PM ISTResearchers have found in a new study a potential causal associations between alopecia areata and blood levels of glutamine, citric acid, glucose, as...
Pemphigus not significantly associated with Psychiatric Disorders: Study Jacinthlyn Sylvia7 Jan 2026 8:15 PM ISTA new study published in the journal of JID Innovations revealed that pemphigus is not significantly associated with an increased risk of most...
Lichen Sclerosus tied to Risk of Vulvar Dysplasia and Malignancy, suggests study Dr Riya Dave6 Jan 2026 10:15 PM ISTResearchers have found in a new study that Lichen sclerosus is linked to a significantly increased risk of vulvar dysplasia and cancer. Clobetasol...
Topical Clascoterone 5% Shows Significant Hair Regrowth Without Systemic Effects in topline data Dr. Kamal Kant Kohli5 Jan 2026 8:00 PM ISTClascoterone 5% topical solution, an anti-androgen that targets the hair follicle androgen receptor without measurable systemic absorption,...
Dietary Supplements Safe and Promising Adjunctive Therapy for Psoriasis, Suggests Study Medha Baranwal4 Jan 2026 10:15 PM ISTChina: A network meta-analysis of 21 randomized controlled trials suggests that curcumin, vitamin D, and XP-828L are the most promising dietary...
Vagus Nerve Stimulation Shows Promise for Treating Facial Redness in Rosacea: Study Medha Baranwal2 Jan 2026 8:15 PM ISTChina: A noninvasive neuromodulation technique may offer a promising new treatment option for patients with erythematotelangiectatic rosacea (ETR), a...
Real-World Evidence Supports Dupilumab in Pediatric and Adult head and neck atopic dermatitis Patients: Study Dr. Shravani Dali1 Jan 2026 8:00 PM ISTResearchers have found in a new real-world study that dupilumab was an effective and safe therapeutic option for head and neck atopic dermatitis,...
Long-Term Frequent Hair Dye Use May Be Linked to Increased Cancer Risk: Study Dr. Shravani Dali31 Dec 2025 9:30 PM ISTEvidence suggests that frequent and long-term use of hair dyes may be associated with an increased risk of certain cancers in specific populations,...
Topical Tofacitinib Matches Tacrolimus in Efficacy With Potential Safety Advantages in Localized Vitiligo: Study Dr. Shravani Dali30 Dec 2025 8:30 PM ISTResearchers have found in a new study that topical tofacitinib showed similar effectiveness to tacrolimus in treating localized vitiligo, with trends...
Ivarmacitinib Shows Rapid, Sustained Efficacy in Moderate-to-Severe Atopic Dermatitis: Study Jacinthlyn Sylvia29 Dec 2025 8:30 PM ISTA new study published in the journal of Inflammopharmacology showed that in individuals with moderate-to-severe atopic dermatitis, ivarmacitinib shows...
